Vimarsana
Biggest News Aggregation in the World

Page 5 - Eugene Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eugene Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eugene Chen Today - Breaking & Trending Today

New Drug Successfully Treats Fatty Liver Disease in Primate Model - Vimarsana News

New Drug Successfully Treats Fatty Liver Disease in Primate Model

Millions of people are affected by nonalcoholic steatohepatitis (NASH), which is a serious liver disease. A newly discovered amino acid compound has been found to successfully treat nonalcoholic fatty liver disease in non-human primates, representing a significant step towards the development of th

Chemists redesign biological PHAs, 'dream' biodegradable plastics - Vimarsana News

Chemists redesign biological PHAs, 'dream' biodegradable plastics

They’ve been called “dream” plastics: polyhydroxyalkanoates, or PHAs. Already the basis of a fledgling industry, they’re a class of polymers naturally created by living microorganisms, or syntheti ...

Dream Plastic: Chemist Aims to Create Biodegradable Plastic - Vimarsana News

Dream Plastic: Chemist Aims to Create Biodegradable Plastic

Polyhydroxyalkanoates or "dream" plastics are polymers naturally produced by living microbes or artificially synthesized from biorenewable feedstocks. Can they be the new biodegradable plastic? Read more here.

Tripeptide Treats Fatty Liver Disease in Non-Human Primates - Vimarsana News

Tripeptide Treats Fatty Liver Disease in Non-Human Primates

Researchers say studies describe a highly translatable NASH model and highlight the need for clinical evaluation of DT-109.

Drug Candidate for Fatty Liver Disease Shows Promise in Animal Models - Vimarsana News

Drug Candidate for Fatty Liver Disease Shows Promise in Animal Models

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates, bringing scientists one step closer to the first human treatment for the condition.